Don’t miss the new podcast series on novel therapies!

The CHS has produced a new podcast series entitled NOVEL THERAPIES FOR BLEEDING DISORDERS.

The series explores therapies that are potentially coming to the Canadian market for the treatment of hemophilia A and B, von Willebrand disease and other rare bleeding disorders such as Glanzmann Thrombasthenia. Our guide to these new therapies is DR. ROY KHALIFÉ, Assistant Professor at the University of Ottawa and co-director of the Ottawa Regional Adult Bleeding Disorders Program at the Ottawa Hospital.

All podcasts are available in video and audio formats on YouTube, Amazon Music, Apple Podcasts, and Spotify.

CLICK HERE for “The potential next therapies for bleeding disorders to enter the Canadian market”

CLICK HERE for “What’s coming for VWD and Glanzmann Thrombasthenia?”